BRISTOL –
The cancer program at Bristol Regional Medical Center has earned a three-year approval with commendation by the American College of Surgeon’s Commission on Cancer.
Bristol Regional received the commendation based on an on-site evaluation by a physician surveyor who determined the hospital met the Commission on Cancer’s standards for comprehensive, quality care. Only 25 percent of hospitals in the United States and Puerto Rico have cancer programs approved by the Commission on Cancer.
Bristol Regional is known across the region for the expert and cutting-edge treatment options available to cancer patients inside the J.D. and Lorraine Nicewonder Cancer Center. The hospital features the region’s only CyberKnife Stereotactic Radiosurgery System, which uses state-of-the-art robotic technology to treat otherwise inoperable tumors.
Also, the hospital is nearing completion of the Jackie Leonard Infusion Center, which will enhance Bristol Regional’s reputation as a leading center for cancer treatment. In the new infusion center, patients who are undergoing chemotherapy treatment will find a spa-inspired environment with new amenities for comfort and larger treatment spaces so family members can support their loved ones during treatment sessions.
Receiving care at a Commission on Cancer-approved program ensures a patient will have access to:
• Comprehensive care, including a range of state-of-the-art services and equipment
• A multispeciality, team approach to coordinate the best treatment options
• Information about ongoing clinical trials and treatment options
• Access to cancer-related information, education and support
• A cancer registry that collects data on type and stage of cancers and treatment results and offers lifelong patient follow-up
• Ongoing monitoring of patients and focus on improvement of care
• Quality care close to home
Established in 1922 by the American College of Surgeons, the Commission on Cancer is a consortium of professional organizations dedicated to improving survival rates and quality of life for cancer patients through standard-setting, prevention, research, education and the monitoring of quality care standards. Its membership includes, in addition to the American College of Surgeons, 42 national organizations that reflect the full spectrum of cancer care.